Ligand validation:8AI1

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 8AI1 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8AI1_SAH_B_403	80%	54%	0.127	0.977	0.65	1.12	-	2	0	0	100%	1
8AI1_SAH_A_403	75%	53%	0.139	0.974	0.74	1.08	1	2	0	0	100%	1
8AI4_SAH_B_403	95%	55%	0.072	0.975	0.8	0.93	1	2	0	0	100%	1
8AI6_SAH_B_403	87%	57%	0.094	0.967	0.68	0.98	-	2	1	0	100%	1
8AI2_SAH_B_403	84%	50%	0.116	0.979	0.9	1.04	1	2	0	0	100%	1
8AI5_SAH_A_403	84%	51%	0.122	0.984	0.81	1.07	1	2	0	0	100%	1
8TDR_SAH_B_1001	100%	25%	0.029	0.996	1.26	1.79	3	4	0	0	100%	1
8TE4_SAH_B_1001	100%	24%	0.031	0.994	1.26	1.81	3	4	0	0	100%	1
8TE3_SAH_C_1001	100%	24%	0.033	0.995	1.27	1.84	3	4	1	0	100%	1
8TE1_SAH_D_1001	100%	25%	0.034	0.992	1.25	1.81	3	4	0	0	100%	1
5PA0_SAH_A_301	100%	32%	0.043	0.994	1.11	1.59	2	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.